Ignite Creation Date:
2024-05-05 @ 6:30 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00490945
Status:
COMPLETED
Last Update Posted:
2014-08-26
First Post:
2007-06-22
Brief Title:
Safety and Efficacy of VEC-162 on Circadian Rhythm in Healthy Adult Volunteers
Sponsor:
Vanda Pharmaceuticals
Organization:
Vanda Pharmaceuticals
Study Overview
Official Title:
A Randomized Double-blind Placebo-controlled Multi-center Study of the Effects of VEC-162 on Circadian Rhythm in Healthy Subjects
Status:
COMPLETED
Status Verified Date:
2014-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess the safety and efficacy of VEC-162 compared to matching placebo on circadian phase shift and sleep parameters
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None